RaNA Therapeutics Receives $20,700,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8e68987-f9a2-4191-8a3c-45137754fe5c&Preview=1 -
Date
1/18/2012 -
Company Name
RaNA Therapeutics -
Mailing Address
25 First Street Cambridge, MA 02141 -
Company Description
RaNA was initially named IncRNA Inc., possibly a reference to intergenic non-coding RNA, the RNA that doesn’t make proteins but still performs a cellular function. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$20,700,000 -
Transaction Round
Series A -
Proceeds Purposes
The Series A funds will be used to accelerate R&D efforts across a range of disease areas, expand RaNA’s broad IP estate in the field of long non-coding RNA, and expand the core team. -
M&A Terms
-
Venture Investor
Atlas Venture -
Venture Investor
SR One -
Venture Investor
Monsanto
